11 results
POCUS Lung Algorithm for the Use of Ultrasound in the Evaluation of Dyspnea 

#Diagnosis #Management #CriticalCare
POCUS Lung Algorithm ... for the Use of Ultrasound ... #Diagnosis #Management ... #Algorithm #Ddxof ... #Lung #Pulmonary
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
- performed on dyspneic ... thickened, irregular pleural ... BLUE #protocol #Algorithm ... #POCUS #Lung #Pulmonary ... #Ultrasound
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... known or suspected malignant ... goals of assessing lung ... #Malignant #Pleural ... Effusions #MPE #Algorithm
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
- performed on dyspneic ... thickened, irregular pleural ... BLUE #protocol #Algorithm ... #POCUS #Lung #Pulmonary ... #Ultrasound
Fibrinous septations in Malignant Pleural Effusion (MPE) - Lung POCUS
 • can be triggered by thoracenteses
Pleural Effusion ... (MPE) - Lung POCUS ... prospective e/o dyspnea ... #clinical #ultrasound ... #pulmonary
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
with CTD, drugs, malignancy ... History: cough, dyspnea ... Rare: pleural effusions ... , pleural thickening ... ILD #diagnosis #management
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... goals of assessing lung ... #Algorithm #Effusion ... #Malignant #Management ... #Pleural #Pulmonary
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... pain, hemoptysis, dyspnea ... residual lesion or is clear ... polyangiitis) • Malignancy ... #Abscess #pulmonary
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
affecting the lungs ... hemoptysis • Dyspnea ... organ system: • Pleura ... tracheobronchial stenosis, malignancy ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
affecting the lungs ... hemoptysis • Dyspnea ... organ system: • Pleura ... tracheobronchial stenosis, malignancy ... TB #Diagnosis #Management